FilingSEC EDGAR8-K
Valion Bio Appoints Interim CEO and Announces Board Changes
· SEC accepted
StageLeadership Change
Filing content
The company appointed Dean Zikria as Interim CEO and announced changes to its Board of Directors and committee chairs.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…